Clinical Investigation of the TECNIS® Next-Generation Intraocular Lens
Completed · Not applicable
Conditions studied: Cataracts
In brief
Prospective, multicenter, bilateral, interventional, controlled, masked (sponsor, subjects, and evaluators), randomized clinical trial.
Key facts
- Study ID
- NCT06377514
- Run by
- Johnson & Johnson Surgical Vision, Inc.
- People needed
- 245
- Starts
- 2024-06-03
- Expected to finish
- 2025-04-23
- Last updated by the study team
- 2026-07-17
Who can join
Age: 22 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- To be considered for enrollment in this study, patient must:
- be at least 22 years old
- have cataracts in both eyes
- sign the written informed consent
- be willing and able to comply with examination procedures
- understand, read and write English to complete informed consent and questionnaires
- be available for study follow-up visits EXCLUSION CRITERIA
- Patient will not be eligible to take part in the study if:
- currently participating in any other clinical study or have participated in a clinical study during the last 30 days
- have a certain disease/illness, such as poorly controlled diabetes
- have certain ocular conditions, such as uncontrolled pressure in the eye
- taking medication that may affect vision
- pregnant, plan to become pregnant during the study, or are breastfeeding
Where it is running
- Empire Eye & Laser Center — Bakersfield, California, United States
- Levenson Eye Associates — Jacksonville, Florida, United States
- Jones Eye Center — Sioux City, Iowa, United States
- OCLI Vision — Garden City, New York, United States
- Cleveland Eye Clinic — Brecksville, Ohio, United States
- Vance Thompson Vision — Sioux Falls, South Dakota, United States
- Berkeley Eye Institute — Houston, Texas, United States
- Whitsett Vision Group — Houston, Texas, United States
- Parkhurst NuVision — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.